Previous Page  74 / 160 Next Page
Information
Show Menu
Previous Page 74 / 160 Next Page
Page Background

626

19. O’Leary C, Wieneke P, Buckley S et al. Celiac disease and irritable

bowel-type symptoms. Am J Gastroenterol 2002; 97: 1463-

1467.

20. Dalrymple J, Bullock I. Diagnosis and management of irritable

bowel syndrome in adults in primary care: summary of NICE

guidance. BMJ 2008; 336: 556-558.

21. Troncone R, Greco L, Mayer M, et al. Latent and potential coeliac

disease. Acta Paediatr 1996; 412: 10-14.

22. Ludvigsson J, Leffler D, Bai C et al. The Oslo definitions for coeliac

disease and related terms. Gut 2013; 62: 43-52.

23. Volta U, Caio G, Stanghellini V, De Giorgio R. The changing clinical

profile of celiac disease: a 15-year experience (1998-2012) in an

Italian referral center. BMC Gastroenterol 2014; 14: 194-202.

24. Brar P, Kwon G, Egbuna I, et al. Lack of correlation of degree of

villous atrophy with severity of clinical presentation of coeliac

disease. Dig Liver Dis 2007; 39: 26-29.

25. Murray J, Rubio-Tapia A, Van Dyke C, et al. Mucosal atrophy in

celiac disease: extent of involvement, correlation with clinical

presentation, and response to treatment. Clin Gastroenterol

Hepatol 2008; 6: 186-193.

26. Matysiak-Budnik T, Malamut G, de Serre N, et al. Long-term

follow-up of 61 coeliac patients diagnosed in childhood:

evolution toward latency is possible on a normal diet. Gut 2007;

56; 1379-1386.

27. Rubio-Tapia A, Hill I, Kelly C, Calderwood A, Murray J. ACG Clinical

Guidelines: Diagnosis and Management of Celiac Disease. Am J

Gastroenterol 2013; 108: 656-676.

28. Ludvigsson J, Bai J, Biagi F, et al.Diagnosis and management

of adult coeliac disease: guidelines from de British Society of

Gastroenterology. 8, 2014, Gut, Vol. 63, págs. 1210-1228.

29. Bai J, FriedM, CorazzaG, et alWorldGastroenterologyOrganisation

Global Guidelines on Celiac Disease. J Clin Gastroenterol 2013;

47 (2): 121-126.

30. Czaja-Bulsa, G. Non coeliac gluten sensitivity. Clinical nutrition

2014, en prensa.

doi.org/10.1016/j.clnu.2014.08.012.

31. Leffler DA, Schuppan D. Update on serologic testing in celiac

disease. Am J Gastroenterol 2010; 105: 2520-2524.

32. McGowan K, Lyon M, Butzner J. Celiac disease and IgA deficiency:

complications of serological testing approaches encountered in

the clinic. Clin Chem 2008; 54: 1203-1209.

33. Oxentenko A, Murray J. Celiac Disease: Ten Things That Every

Gastroenterologist Should Know. Clin Gastroenterol Hepatol

2014, en prensa. doi: 10.1016/j.cgh.2014.07.024.

34. Oxentenko A, Grisolano S, Murray J, Burgart L, Dierkhising R,

Alexander J. The insensitivity of endoscopic markers in celiac

disease. Am J Gastroenterol 2002; 97: 933-938.

35. Gasbarrini A, Ojetti V, Cuoco L, et al. Lack of endoscopic

visualization of intestinal villi with the “immersion technique”

in overt atrophic celiac disease. Gastrointest Endosc 2003; 57:

348-351.

36. Siegel L, Stevens P, Lightdale C, et al. Combined magnification

endoscopy with chromoendoscopy in the evaluation of patients

with suspected malabsorption. Gastrointest Endosc 1997; 46:

226-230.

37. Kurien M, Evans K, Hopper A, Hale M, Cross S, Sanders D.

Duodenal bulb biopsies for diagnosing adult celiac disease: is

there an optimal biopsy site?. Gastrointestinal Endoscopy 2012;

75: 1190-1196.

38. Atlas D, Rubio-Tapia A , Van Dyke C, et al. Capsule endoscopy

in nonresponsive celiac disease. Gastrointest Endosc 2011; 74:

1315-1322.

39. Kav T, Sivri B. Is enteroscopy necessary for diagnosis of celiac

disease? World J Gastroenterol 2012; 18: 4095-4101.

40. Oberhuber, G. Histopathology of celiac disease. Biomed

Pharmacother 2000; 54: 368-372.

41. Corazza G, Villanacci V, Zambelli C, et al. Comparison of the

interobserver reproducibility with different histologic criteria

used in celiac disease. Clin Gastroenterol Hepatol 2007; 5:

838-843.

42. Guandalini S, Ventura A , Ansaldi N, et al. Diagnosis of coeliac

disease: time for a change? Arch Dis Child 1989; 64: 1320-

1324.

43. Husby S, Koletzko S , Korponay-Szabo I, et al. European Society for

Pediatric Gastroenterology, Hepatology, and Nutrition guidelines

for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr

2012; 54: 136-160.

44. Walker M, Murray J, Ronkainen J, et al. Detection of celiac

disease and lymphocytic enteropathy by parallel serology and

histopathology in a population-based study. Gastroenterology

2010; 139: 112-119.

45. Aziz I, Evans K, Hopper A, Smillie D, Sanders D. A prospective study

into the aetiology of lymphocytic duodenosis. Aliment Pharmacol

Ther 2010; 32: 1392-1397.

46. Beltran L, Koenig M, Egner W, et al. High-titre circulating tissue

transglutaminase-2 antibodies predict small bowel villous

atrophy, but decision cut-off limits must be locally validated.

Exp Immunol 2014; 176: 190-198.

47. Mubarak A, Wolters V, Gmelig-Meyling F, Ten Kate F, Houwen

R. Tissue transglutaminase levels above 100 U/mL and celiac

disease: a prospective study. World J Gastroenterol 2012; 18:

4399-4403.

48. Araya M, Oyarzun A, Lucero Y, Espinosa N, Perez-Bravo F. DQ2,

DQ7 and DQ8 Distribution and Clinical Manifestations in Celiac

Cases and Their First-Degree Relatives. Nutrients 2015; 7:

4955-4965.

49. Wouters J, Weijerman M, van Furth A, et al. Prospective human

leukocyte antigen, endomysium immunoglobulin A antibodies,

and transglutaminase antibodies testing for celiac disease in

children with Down syndrome. J Pediatr 2009; 154: 239-242.

50. Akobeng AK, Thomas AG. Systematic review: tolerable amount of

gluten for people with coeliac disease. Aliment Pharmacol Ther

2008; 27 (11): 1044-1052.

51. Hall N, Rubin G, Charnock A. Systematic review: adherence to a

gluten-free diet in adult patients with coeliac disease. Aliment

Pharmacol Ther 2009; 30: 315-330.

52. Aziz I, Evans K, Papageorgiou V, et al. Are patients whit coeliac

disease seeking alternative therapies to gluten-free diet?

Gastrointestin Liver Dis 2011; 20: 27-31.

[REV. MED. CLIN. CONDES - 2015; 26(5) 613-627]